vs

Side-by-side financial comparison of Fresenius Medical Care AG (FMS) and L3Harris (LHX). Click either name above to swap in a different company.

L3Harris is the larger business by last-quarter revenue ($5.7B vs $5.5B, roughly 1.0× Fresenius Medical Care AG). L3Harris runs the higher net margin — 8.9% vs 7.9%, a 1.0% gap on every dollar of revenue. On growth, L3Harris posted the faster year-over-year revenue change (24.0% vs -0.3%).

Fresenius Medical Care AG & Co. KGaA is a German healthcare company which provides kidney dialysis services through a network of 4,171 outpatient dialysis centers, serving 345,425 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo dialysis 3 times per week for the rest of their lives.

L3Harris Technologies, Inc. is an American technology company, defense contractor, and information technology services provider that produces products for command and control systems, wireless equipment, tactical radios, avionics and electronic systems, night vision equipment, intelligence, surveillance and reconnaissance (C3ISR) systems and products, ocean systems, instrumentation, navigation products, training devices and services, and both terrestrial/spaceborne antennas for use in the govern...

FMS vs LHX — Head-to-Head

Bigger by revenue
LHX
LHX
1.0× larger
LHX
$5.7B
$5.5B
FMS
Growing faster (revenue YoY)
LHX
LHX
+24.3% gap
LHX
24.0%
-0.3%
FMS
Higher net margin
LHX
LHX
1.0% more per $
LHX
8.9%
7.9%
FMS

Income Statement — Q4 FY2025 vs Q1 FY2027

Metric
FMS
FMS
LHX
LHX
Revenue
$5.5B
$5.7B
Net Profit
$434.2M
$512.0M
Gross Margin
27.4%
175.6%
Operating Margin
11.7%
11.4%
Net Margin
7.9%
8.9%
Revenue YoY
-0.3%
24.0%
Net Profit YoY
240.4%
32.6%
EPS (diluted)
$2.72

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FMS
FMS
LHX
LHX
Q1 26
$21.9B
Q4 25
$5.5B
$5.7B
Q2 25
$5.4B
Q1 25
$5.5B
Q4 24
$5.5B
Q3 24
$5.3B
Q2 24
$5.3B
Q1 24
$5.2B
Net Profit
FMS
FMS
LHX
LHX
Q1 26
Q4 25
$434.2M
$462.0M
Q2 25
$458.0M
Q1 25
$453.0M
Q4 24
$127.6M
Q3 24
$400.0M
Q2 24
$366.0M
Q1 24
$283.0M
Gross Margin
FMS
FMS
LHX
LHX
Q1 26
25.7%
Q4 25
27.4%
26.4%
Q2 25
24.6%
Q1 25
25.3%
Q4 24
25.0%
Q3 24
26.8%
Q2 24
25.7%
Q1 24
25.9%
Operating Margin
FMS
FMS
LHX
LHX
Q1 26
9.7%
Q4 25
11.7%
11.0%
Q2 25
10.5%
Q1 25
10.3%
Q4 24
5.1%
Q3 24
9.4%
Q2 24
9.0%
Q1 24
7.3%
Net Margin
FMS
FMS
LHX
LHX
Q1 26
Q4 25
7.9%
8.2%
Q2 25
8.4%
Q1 25
8.2%
Q4 24
2.3%
Q3 24
7.6%
Q2 24
6.9%
Q1 24
5.4%
EPS (diluted)
FMS
FMS
LHX
LHX
Q1 26
Q4 25
$2.46
Q2 25
$2.44
Q1 25
$2.37
Q4 24
Q3 24
$2.10
Q2 24
$1.92
Q1 24
$1.48

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FMS
FMS
LHX
LHX
Cash + ST InvestmentsLiquidity on hand
$1.7B
$590.0K
Total DebtLower is stronger
$350.0K
Stockholders' EquityBook value
$15.4B
$19.7M
Total Assets
$33.5B
$41.4M
Debt / EquityLower = less leverage
0.02×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FMS
FMS
LHX
LHX
Q1 26
$1.1B
Q4 25
$1.7B
$339.0M
Q2 25
$482.0M
Q1 25
$615.0M
Q4 24
$1.3B
Q3 24
$539.0M
Q2 24
$547.0M
Q1 24
$477.0M
Total Debt
FMS
FMS
LHX
LHX
Q1 26
$10.4B
Q4 25
$11.0B
Q2 25
$11.0B
Q1 25
$11.1B
Q4 24
Q3 24
$11.1B
Q2 24
$10.5B
Q1 24
$11.1B
Stockholders' Equity
FMS
FMS
LHX
LHX
Q1 26
$19.6B
Q4 25
$15.4B
$19.5B
Q2 25
$19.3B
Q1 25
$19.5B
Q4 24
$17.0B
Q3 24
$19.0B
Q2 24
$18.8B
Q1 24
$18.7B
Total Assets
FMS
FMS
LHX
LHX
Q1 26
$41.2B
Q4 25
$33.5B
$41.0B
Q2 25
$41.2B
Q1 25
$42.0B
Q4 24
$36.3B
Q3 24
$41.9B
Q2 24
$41.7B
Q1 24
$41.8B
Debt / Equity
FMS
FMS
LHX
LHX
Q1 26
0.53×
Q4 25
0.56×
Q2 25
0.57×
Q1 25
0.57×
Q4 24
Q3 24
0.58×
Q2 24
0.56×
Q1 24
0.60×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FMS
FMS
LHX
LHX
Operating Cash FlowLast quarter
$2.9B
$-95.0M
Free Cash FlowOCF − Capex
$-187.0M
FCF MarginFCF / Revenue
-3.3%
Capex IntensityCapex / Revenue
1.7%
Cash ConversionOCF / Net Profit
6.67×
-0.19×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FMS
FMS
LHX
LHX
Q1 26
Q4 25
$2.9B
$546.0M
Q2 25
$640.0M
Q1 25
$1.1B
Q4 24
$2.6B
Q3 24
$780.0M
Q2 24
$754.0M
Q1 24
$-104.0M
Free Cash Flow
FMS
FMS
LHX
LHX
Q1 26
Q4 25
$427.0M
Q2 25
$552.0M
Q1 25
$1.0B
Q4 24
Q3 24
$702.0M
Q2 24
$657.0M
Q1 24
$-219.0M
FCF Margin
FMS
FMS
LHX
LHX
Q1 26
Q4 25
7.5%
Q2 25
10.2%
Q1 25
18.3%
Q4 24
Q3 24
13.3%
Q2 24
12.4%
Q1 24
-4.2%
Capex Intensity
FMS
FMS
LHX
LHX
Q1 26
Q4 25
2.1%
Q2 25
1.6%
Q1 25
2.1%
Q4 24
Q3 24
1.5%
Q2 24
1.8%
Q1 24
2.2%
Cash Conversion
FMS
FMS
LHX
LHX
Q1 26
Q4 25
6.67×
1.18×
Q2 25
1.40×
Q1 25
2.49×
Q4 24
20.20×
Q3 24
1.95×
Q2 24
2.06×
Q1 24
-0.37×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FMS
FMS

Segment breakdown not available.

LHX
LHX

Space & Mission Systems$3.0B52%
Communication & Spectrum Dominance$1.9B32%
Missile Solutions$990.0M17%

Related Comparisons